|
|
|
Volumn 9, Issue 2, 2002, Pages 115-119
|
|
United Kingdom Prospective Diabetes Study: Implications for metformin
a
|
|
Author keywords
Complications; Insulin resistance; Metformin; Survival; Type 2 diabetes
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CHLORPROPAMIDE;
CYANOCOBALAMIN;
FOLIC ACID;
GLIBENCLAMIDE;
GLUCOSE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METFORMIN;
ORAL ANTIDIABETIC AGENT;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
SULFONYLUREA DERIVATIVE;
VERY LOW DENSITY LIPOPROTEIN;
CARDIOVASCULAR RISK;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DIABETES CONTROL;
DIABETIC ANGIOPATHY;
DIABETIC MICROANGIOPATHY;
DIABETIC RETINOPATHY;
DIET THERAPY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG USE;
EXERCISE;
GASTROINTESTINAL SYMPTOM;
HEALTH CARE COST;
HEART INFARCTION;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
HYPOGLYCEMIA;
INSULIN RESISTANCE;
LACTIC ACIDOSIS;
LONG TERM CARE;
METABOLIC DISORDER;
MICROALBUMINURIA;
MONOTHERAPY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
OUTCOMES RESEARCH;
PROSPECTIVE STUDY;
REVIEW;
SURVIVAL;
TASTE DISORDER;
UNITED KINGDOM;
|
|
EID: 0036185472
PISSN: 09696113
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (13)
|
